Related Experiment Video
Updated: Jul 22, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Association of Thrombotic Markers With Severity of Pediatric-Onset Systemic Lupus Erythematosus
Sheren Esam Maher1, Ahmed Ragab Abdul-Badia1, Mostafa Ahmed Abu El-Ela2
1Department of Pediatrics, Faculty of Medicine, Minia University, El-Minya, Egypt.
Insights
Thrombomodulin and D-dimer levels are elevated in children with pediatric systemic lupus erythematosus (p-SLE). Higher levels of these thrombotic markers correlate with increased disease activity, aiding in distinguishing severe cases.
Area of Science:
- Pediatric Rheumatology
- Hematology
- Immunology
Background:
- Pediatric-onset systemic lupus erythematosus (p-SLE) is a chronic autoimmune disease with variable clinical manifestations.
- Assessing disease activity and identifying predictive markers are crucial for effective management of p-SLE.
- Thrombotic events can be a serious complication in patients with SLE.
Purpose of the Study:
- To investigate the relationship between thrombotic markers, specifically thrombomodulin and D-dimer, and disease severity in pediatric-onset systemic lupus erythematosus (p-SLE).
- To determine if these markers can differentiate between low and moderate-to-high disease activity levels in children with p-SLE.
Main Methods:
- A cohort of 40 children diagnosed with p-SLE was divided into low activity (laSLE) and moderate-high activity (mhaSLE) groups based on the Systemic Lupus Erythematous Disease Activity Index (SLEDAI).
- Forty healthy children served as a control group.
- Serum levels of thrombomodulin and D-dimer were quantified in all participants.
Main Results:
- Children with p-SLE, across both activity groups, exhibited significantly higher mean thrombomodulin and D-dimer levels compared to healthy controls.
- The moderate-high activity SLE (mhaSLE) group demonstrated significantly elevated thrombomodulin and D-dimer levels compared to the low activity SLE (laSLE) group.
- Both thrombomodulin and D-dimer showed significant positive correlations with SLEDAI scores, indicating a link to disease severity.
Conclusions:
- Thrombomodulin and D-dimer serve as valuable biomarkers for assessing disease activity in p-SLE.
- These markers effectively distinguish children with severe p-SLE activity from those with milder disease, aiding in clinical stratification.
Objective:
To assess the relation of thrombotic markers, thrombomodulin and D-dimer levels to the disease severity in pediatric onset systemic lupus erythematosus (p-SLE) measured by the Systemic Lupus Erythematous Disease Activity Index (SLEDAI).
Methods:
40 children with p-SLE were grouped according to SLEDAI into: low activity SLE group (laSLE) and moderate-high activity SLE group (mhaSLE). 40 healthy children were included as control group. Serum thrombomodulin, and D-dimer levels were measured for all enrolled children.
Results:
The low activity and moderate-high activity SLE groups had significantly higher mean (SD) thrombomodulin [7.2 (1.83) mg/mL and 9.86 (3.29) mg/mL, respectively vs 5.85 (1.41) mg/mL; P<0.001] and D-dimer (r=0.42, P=0.006) levels than controls. Furthermore, the mhaSLE group had significantly higher thrombomodulin levels and D-dimer (r = 0.42, P= 0.006) levels than the laSLE group (P=0.008 and 0.006). Thrombomodulin and D-dimer had significant positive correlations with SLEDAI.
Conclusion:
Thrombomodulin and D-dimer are valuable markers for p-SLE activity, discriminating children with severe disease activity from those with low disease activity.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Nephrotic Syndrome II : Assessment and Medical Management

